BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-1051-2014

NuVision Pharmacy, Inc. · Dallas, TX

Class I — life-threatening Terminated 1395 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

HCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244

Lot / code: Lot #s: N06252012@6 Exp 6/25/13; N01042013@15 Exp 1/29/14; N05072012@3 Exp 2/1/15

Quantity: 285 vials

Reason for recall

Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.

Recall record

Recall number
D-1051-2014
Classification
Class I
Status
Terminated
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Press Release
Distribution
Nationwide
Recall initiated
2013-04-15
Classified by FDA Center
2014-01-30
FDA published
2014-02-05
Terminated
2017-02-08
Recalling firm
NuVision Pharmacy, Inc.
Firm location
Dallas, TX

‹ All recalls